Y0002196

Deferasirox

CRS, European Pharmacopoeia (EP) Reference Standard

• 別名: 4-[3,5-bis(2-Hydroxyphenyl)-1H-1,2,4-triazol-1-yl]benzoic acid
• 実験式（ヒル表記法）: C₂₁H₁₅N₃O₄
• CAS番号: 201530-41-8
• 分子量: 373.36
• MDL番号: MFCD09951804
• UNSPSCコード: 41116107
• NACRES: NA.24

特性

• APIファミリー: deferasirox
• メーカー／製品名: EDQM
• 保管温度: 2-8°C
• InChI: 1S/C21H15N3O4/c25-17-7-3-1-5-15(17)19-22-20(16-6-2-4-8-18(16)26)24(23-19)14-11-9-13(10-12-14)21(27)28/h1-12,22-23H,(H,27,28)/b19-15-,20-16+
• InChI Key: FMSOAWSKCWYLBB-VBGLAJCLSA-N

詳細

詳細

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

アプリケーション

Deferasirox EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

生物化学的／生理学的作用

Deferasirox is an orally available iron chelator used clinically for reduction of chronic iron overload in diseases such as β-thalassemia.

包装

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

その他情報

Sales restrictions may apply.

安全性情報

• ピクトグラム: GHS07,GHS09
• シグナルワード: Warning
• 危険有害性情報: H302,H400
• 注意書き: P264 - P270 - P273 - P301 + P312 - P391 - P501
• 危険有害性の分類: Acute Tox. 4 Oral - Aquatic Acute 1
• 保管分類コード: 11 - Combustible Solids
• WGK: WGK 3
• 引火点(°F): Not applicable
• 引火点(℃): Not applicable